Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Carlos G Santos-Gallego"'
Publikováno v:
Revista Colombiana de Cardiología, Vol 19, Iss 4, Pp 180-183 (2012)
Externí odkaz:
https://doaj.org/article/69559bc20cc74972a83e22cfb6687500
Publikováno v:
Revista Colombiana de Cardiología, Vol 20, Iss 2, Pp 111-113 (2013)
Externí odkaz:
https://doaj.org/article/6aa3df68a2e944278d2541318fea773a
Autor:
Francesco Perone, Marco Bernardi, Alban Redheuil, Dario Mafrica, Edoardo Conte, Luigi Spadafora, Fiona Ecarnot, Lale Tokgozoglu, Carlos G. Santos-Gallego, Sergio Emanuel Kaiser, Federica Fogacci, Annabelle Sabouret, Deepak L. Bhatt, Francesco Paneni, Maciej Banach, Raul Santos, Giuseppe Biondi Zoccai, Kausik K. Ray, Pierre Sabouret
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 17, p 5563 (2023)
Optimal risk assessment for primary prevention remains highly challenging. Recent registries have highlighted major discrepancies between guidelines and daily practice. Although guidelines have improved over time and provide updated risk scores, they
Externí odkaz:
https://doaj.org/article/0f1bbc5a72c348d188c854a42c12e750
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 10 (2022)
Externí odkaz:
https://doaj.org/article/dd6ceb9073704e9cb5d917d7f0fee5e7
Autor:
Connor P. Oates, Carlos G. Santos‐Gallego, Alex Smith, Binaya Basyal, Noah Moss, Iwanari Kawamura, Daniel R. Musikantow, Mohit K. Turagam, Marc A. Miller, William Whang, Srinivas R. Dukkipati, Vivek Y. Reddy, Jacob S. Koruth
Publikováno v:
Journal of Cardiovascular Electrophysiology. 34:1277-1285
Publikováno v:
Revista Española de Cardiología. 75:834-842
Publikováno v:
Journal of Cardiac Failure. 29:53-55
Autor:
Carlos G. Santos-Gallego, Juan Antonio Requena-Ibáñez, Belen Picatoste, Brian Fardman, Kiyotake Ishikawa, Renata Mazurek, Michael Pieper, Samantha Sartori, Jorge Rodriguez-Capitán, Valentin Fuster, Juan J. Badimon
Publikováno v:
Circulation: Cardiovascular Imaging. 16
Background: SGLT2i (sodium-glucose cotransporter-2 inhibitors) improve clinical outcomes in patients with heart failure, but the mechanisms of action are not completely understood. SGLT2i increases circulating levels of ketone bodies, which has been
Publikováno v:
Revista Española de Cardiología. 75:858-860
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 22 (2018)
See Article by Cowan et al
Externí odkaz:
https://doaj.org/article/d0134a0f9376445cb3bf50dc4b65e33b